Catalepsy, DOPAC, and acetylcholine during chronic fluphenazine administration.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002375:Catalepsy / Q000139:chemically induced*; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D005476:Fluphenazine / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009830:Olfactory Bulb / Q000187:drug effects / Q000378:metabolism; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D013997:Time Factors
D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D000109:Acetylcholine; D005476:Fluphenazine